Researchers have found that pharmacy benefit managers (PBMs) — organizations that negotiate access to medicines for most patients in the United States — steer patients to use their own pharmacies. However, these pharmacies appear less used in Medicare than in other market segments. These PBMs are part of integrated health care conglomerates that own insurance companies and pharmacies, which may create conflicts of interest.